BioMérieux S.A.
BIM
Rankning i aktier
#1758
bioMérieux S.A. is a global entity operating across the Americas, Europe, the... bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
Aktiekurs
$101.95
Marknadsvärde
$12.00B
Förändring (1 dag)
-1.43%
Förändring (1 år)
-20.17%
Land
FR
Handel BioMérieux S.A. (BIM)
Kategori
Healthcare
Historik för aktiesplit för BioMérieux S.A. (BIM)
Aktien BioMérieux S.A. (symbol: BIM) har genomgått totalt 1 aktiesplitar.
Den senaste spliten skedde den Sep 20, 2017.
En BIM-aktie köpt före Sep 20, 2017 motsvarar nu 3 BIM-aktier.
Den senaste spliten skedde den Sep 20, 2017.
En BIM-aktie köpt före Sep 20, 2017 motsvarar nu 3 BIM-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| 2017-09-20 | 3:1 | x3 | x3 |
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|
